Insmed INC Form 4 insider transactions

Insmed Inc.'s Chief People Strategy Officer, Nicole Schaeffer, sold shares to cover tax obligations and broker fees, while also receiving stock options and restricted stock units.

Insmed's Chief Commercial Officer, John Drayton Wise, engaged in multiple stock transactions, including option exercises, sales, and RSU vesting, as part of a pre-arranged 10b5-1 trading plan.

Insmed's CEO, William Lewis, sold shares to cover tax obligations, received a stock option grant, and acquired restricted stock units.

Insmed's Chief Legal Officer, Michael Alexander Smith, reported multiple transactions involving the company's stock, including sales to cover tax obligations and the acquisition of restricted stock units and stock options.

Insmed Inc.'s Chief Operating Officer, Roger Adsett, engaged in multiple stock transactions, including sales to cover tax obligations and the acquisition of restricted stock units and stock options.

Insmed Inc.'s CEO, William Lewis, executed multiple stock transactions, including the exercise of stock options and the sale of shares, under a pre-arranged 10b5-1 trading plan.

Insmed's CEO, William Lewis, exercised stock options and sold shares of common stock on December 19, 2024, under a pre-arranged 10b5-1 trading plan.

Insmed's CEO, William Lewis, engaged in multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Chief Legal Officer Michael Smith reports exercising stock options and selling shares of Insmed Inc. under a pre-arranged 10b5-1 trading plan.

Chief Medical Officer Martina Flammer exercised stock options and sold shares of Insmed Inc. under a pre-arranged 10b5-1 trading plan.

S. Nicole Schaeffer, Chief People Strategy Officer at Insmed Inc., exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Martina Flammer, Chief Medical Officer of Insmed Inc., exercised stock options and sold shares of common stock on September 6, 2024, under a pre-arranged 10b5-1 trading plan.

Director Melvin Sharoky reported a gift of Insmed shares and changes in beneficial ownership, including holdings through family foundations and LLCs.

Michael Smith, Chief Legal Officer of Insmed Inc., reports the exercise of stock options and subsequent sale of shares on August 12, 2024.

S. Nicole Schaeffer, Chief People Strategy Officer of Insmed Inc., sold 9,469 shares of common stock at an average price of $72.49 on August 12, 2024.

Chief Legal Officer Michael Alexander Smith reports a transaction involving Insmed Inc. common stock related to tax withholding on vesting Restricted Stock Units.

Chief Medical Officer Martina Flammer exercised stock options and sold shares of Insmed Inc. under a pre-arranged 10b5-1 trading plan.

S. Nicole Schaeffer, Chief People Strategy Officer at Insmed Inc., reports the exercise of stock options and sale of common stock under a pre-arranged 10b5-1 trading plan.

Chief Commercial Officer John Drayton Wise reports stock sales and option exercises at Insmed Inc. on May 28, 2024, under a pre-arranged 10b5-1 trading plan.

Chief Legal Officer Michael Smith exercised stock options and sold shares of Insmed Inc. common stock on May 28, 2024, under a pre-arranged 10b5-1 trading plan.

S. Nicole Schaeffer, Chief People Strategy Officer at Insmed Inc., reports exercising stock options and selling shares under a pre-arranged 10b5-1 trading plan.

Chief Medical Officer Martina Flammer executed stock options and sold shares of Insmed Inc. common stock under a pre-arranged 10b5-1 trading plan.

Insmed's Chief Financial Officer, Sara Bonstein, exercised stock options and sold a significant number of shares under a pre-arranged 10b5-1 trading plan.

Chief Medical Officer Martina Flammer sold 4,642 shares of Insmed Inc. common stock at $25.09 per share on May 17, 2024, under a pre-arranged 10b5-1 trading plan.

Insmed Inc.'s Chief Operating Officer, Roger Adsett, sold 5,945 shares of common stock at a price of $25.09 per share on May 17, 2024, under a pre-arranged 10b5-1 trading plan.

Chief Commercial Officer John Drayton Wise reports acquisition of restricted stock units and stock options, as well as the sale of common stock to cover tax obligations.

Chief Legal Officer Michael Smith reports acquisition and disposal of Insmed Inc. stock and stock options.

Chief People Strategy Officer Nicole Schaeffer Orlov reports acquisition of restricted stock units (RSUs) and subsequent sale of shares to cover tax obligations.

Insmed Inc. CEO William Lewis reports acquisition and disposal of common stock and stock options.

Martina Flammer, Chief Medical Officer of Insmed Inc., reports acquisition of restricted stock units and stock options, as well as the sale of common stock to cover tax obligations.